🟢 Picard Medical is trading 10.14% up in pre-market, possibly rebounding after September 21's 17.13% drop

Picard Medical is trading at $4.64 (+10.14%) in pre-market amid no verified company-specific catalyst identified for September 22, 2026.

• Earlier NYSE American compliance-plan acceptance is the latest company-related coverage, not a new event.
• Backdrop is mixed to slightly softer: S&P 500 down 0.11% and NASDAQ Composite down 0.14%; sentiment does not explain the gain.
• The move may reflect speculative rebound activity after Picard Medical fell 17.13% in the September 21 regular session; causation remains unconfirmed.